Whitehawk Therapeutics, Inc. (WHWK) Misses Q2 EPS by 101c

Whitehawk Therapeutics, Inc. (NASDAQ: WHWK) reported Q2 EPS of ($0.76), $1.01 worse than the analyst estimate of $0.25.

For earnings history and earnings-related data on Whitehawk Therapeutics, Inc. (WHWK) click here.

You May Also Be Interested In

• SailPoint Technologies Holdings (SAIL) PT Raised to $25 by Cantor Fitzgerald on Solid Checks
• H.C. Wainwright Reiterates Buy Rating on Alpha Tau Medical Ltd. (DRTS)
• Comstock Resources (CRK) Halted, News Pending